Adiponectin
Adiponectin (ADIPOQ, also known as ACRP30, apM1, GBP28 and ACDC) is a secreted adipokine that helps control fat metabolism and insulin sensitivity. It circulates in plasma and acts through the receptors ADIPOR1 and ADIPOR2. Browse Assay Genie's current range of Adiponectin research reagents below, or read on for the biology behind the target.
Adiponectin is an important adipokine involved in the control of fat metabolism and insulin sensitivity. It acts by binding its receptors, ADIPOR1 or ADIPOR2, and has a direct anti-diabetic effect. It also has anti-atherogenic and anti-inflammatory activities. In the liver and skeletal muscle it stimulates AMPK phosphorylation and activation, which enhances glucose utilisation and fatty-acid combustion.
The protein also opposes inflammatory signalling. Adiponectin antagonises TNF by negatively regulating its expression in tissues such as liver and macrophages, and by counteracting its effects. It inhibits endothelial NF-kappa-B signalling through a cAMP-dependent pathway. It may also play a role in cell growth, angiogenesis and tissue remodelling by binding and sequestering various growth factors, with distinct binding affinities depending on the complex type: LMW, MMW or HMW.
The ADIPOQ gene is expressed exclusively in adipose tissue according to NCBI Gene. It encodes a protein with similarity to collagens X and VIII and to complement factor C1q, and HGNC places it in the C1q and TNF related group. The previous HGNC name was adipocyte, C1Q and collagen domain containing. The secreted protein circulates in plasma and is involved in metabolic and hormonal processes. Mutations in the gene are associated with adiponectin deficiency, and several alternatively spliced variants encode the same protein. The mouse ortholog is Adipoq.
Adiponectin regulates fat metabolism and insulin sensitivity and has a direct anti-diabetic effect, making it a central adipokine in metabolic studies.
Adiponectin stimulates AMPK phosphorylation and activation in liver and skeletal muscle, enhancing glucose utilisation and fatty-acid combustion.
Adiponectin has anti-inflammatory and anti-atherogenic activities, antagonises TNF and inhibits endothelial NF-kappa-B signalling via a cAMP-dependent pathway.
The gene is expressed exclusively in adipose tissue, and its product circulates in plasma in metabolic and hormonal processes.
Adiponectin is an adipokine that controls fat metabolism and insulin sensitivity by binding ADIPOR1 or ADIPOR2. It activates AMPK in liver and skeletal muscle, antagonises TNF, and has anti-atherogenic and anti-inflammatory activities. It may also bind and sequester growth factors.
The gene symbol is ADIPOQ, and aliases include ACRP30, apM1, GBP28 and ACDC. The HGNC name is adiponectin, C1Q and collagen domain containing; the previous name was adipocyte, C1Q and collagen domain containing. Alternatively spliced variants encode the same protein.
NCBI Gene reports that mutations in ADIPOQ are associated with adiponectin deficiency. A mouse ortholog, Adipoq, is recorded. The protein's anti-diabetic, anti-atherogenic and anti-inflammatory activities make it relevant to metabolic research; check the datasheet of any product for its validated reactivity.
Adiponectin receptors, adipokines, inflammatory mediators and metabolic signalling partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15848; product specifications from Assay Genie datasheets.